Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the.

Slides:

Advertisements

Similar presentations

Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.

Advertisements

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.

Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with.

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer Victor E. Chen, BS, Erin.

John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy Fady F. Youssef, MS, Parag.

Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial Susanne M.

Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma

Preoperative endorectal brachytherapy in the treatment of locally advanced rectal cancer: Rethinking neoadjuvant treatment Matthew C. Biagioli, MD, MS,

Neoadjuvant Chemotherapy for Breast Cancer Increases the Rate of Breast Conservation: Results from the National Cancer Database Brigid K. Killelea, MD,

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.

US radiation oncology practice patterns for posttreatment survivor care Bridget F. Koontz, MD, Rashmi Benda, MD, Jennifer De Los Santos, MD, Karen E.

Volume 143, Issue 5, Pages e437S-e454S (May 2013)

Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the.

Influence of robotic-assisted laparoscopic hysterectomy on vaginal cuff healing and brachytherapy initiation in endometrial carcinoma patients John M.

Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.

Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary Lawrence B. Marks, MD, Robert.

Brenda G. Clark, PhD, Robert J

Safety of differential radiation dosing in lymph node positive necks treated with IMRT Stephen Sozio, MBS, Zorimar Rivera-Núñez, PhD, Omar Mahmoud, MD,

My Path from Hiroshima to Houston

Dosimetric comparison of 3-dimensional conformal radiation therapy and intensity modulated radiation therapy and impact of setup errors in lower limb.

Does Karnofsky Performance Status of Patients With Cirrhosis on the Transplant Waitlist Meet the Eyeball Test? Elliot B. Tapper, MD Clinical Gastroenterology.

US radiation oncology practice patterns for posttreatment survivor care Bridget F. Koontz, MD, Rashmi Benda, MD, Jennifer De Los Santos, MD, Karen E.

Upper abdominal normal organ contouring guidelines and atlas: A Radiation Therapy Oncology Group consensus Salma K. Jabbour, MD, Sameh A. Hashem, MD,

Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality.

Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures Daniel J. Lee, MD, MS, Daniel.

Brian N. Arnold, MD, Daniel C. Thomas, MD, MPH, Joshua E

Impact of radiotherapy dose on dentition breakdown in head and neck cancer patients Mary P. Walker, DDS, PhD, Brian Wichman, MS, An-Lin Cheng, PhD, James.

Postoperative Adjuvant Therapy Improves Survival in Pathologic Nonresponders After Neoadjuvant Chemoradiation for Esophageal Squamous Cell Carcinoma:

Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent.

Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection Shalini Garg, MD,

Latest information for the thoracic surgeon from the Annual Meeting of the American Society of Clinical Oncology Sarita Dubey, MD, Giorgio Scagliotti,

Impact of the ASCO 2007 Presentation of HOG Lun 01-24/USO-023 on the Prescribing Plans of American Medical Oncologists for Patients with Stage IIIB Non-small.

Efficacy of fiducial marker-based image-guided radiation therapy in prostate tomotherapy and potential dose coverage improvement using a patient positioning.

ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer Xiaoying Liang, PhD, Dandan Zheng, PhD, Maria Mamalui-Hunter,

Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy Todd.

The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non–Small Cell Lung Cancer Eric D. Miller, MD,

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

Yang Zhang, MD, Haiquan Chen, MD, PhD

A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596):

Effect of Daily and Every Other Day Stereotactic Body Radiation Therapy Schedules on Treatment-Related Fatigue in Patients With Hepatocellular Carcinoma

An Editorial Note: The Long Arm of Practical Radiation Oncology

Ronald C. Chen, MD, MPH, Karen E. Hoffman, MD, David J

Burnout and Resiliency in Canadian Oncology Residents: A Nationwide Resident and Program Director Survey Hannah Dahn, MD, Angela McGibbon, MD, David.

Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: An ASTRO Consensus Paper Jean L. Wright, MD, Sue S. Yom, MD, PhD, MAS,

Safety considerations for IMRT: Executive summary

Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysis William A. Stokes, MD, Brian.

Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer Elaine Y.L. Leung, MB ChB,

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Definition of medical event is to be based on the total source strength for evaluation of permanent prostate brachytherapy: A report from the American.

Treatment of Colorectal Cancer

Changing practice patterns for breast cancer radiation therapy with clinical pathways: An analysis of hypofractionation in a large, integrated cancer.

Predictors of Surgery and Consult with an Oncologist for Adjuvant Chemotherapy in Early Stage NSCLC Patients in Alberta, Canada Marcy Winget, PhD, Jennifer.

Pathologic complete response after esophagectomy following neoadjuvant chemoradiation therapy for esophageal carcinoma: A cure sometimes? Shawn S. Groth,

Radiation recall precipitated by iodinated nonionic contrast

Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base Susan E. Combs, MA, Jacquelyn.

Pain Response Rates After Conventional Radiation Therapy for Bone Metastases in Prospective Nonrandomized Studies: A Systematic Review Tetsuo Saito,

Using Smaller-Than-Standard Radiation Treatment Margins Does Not Change Survival Outcomes in Patients with High-Grade Gliomas Kripa Guram, BS, Mark Smith,

Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors Sean M. Parker, BS, R. Alfredo Siochi,

Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018 Thomas M. Pisansky, MD, Ian M. Thompson,

After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10% Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular.

Which patients pursue fertility preservation treatments

Induction Therapy For Locally Advanced Thymoma

Manisha Palta, MD, Devon Godfrey, PhD, Karyn A

A Review of First-Line Treatment for Small-cell Lung Cancer

Treating Locally Advanced Disease: An Analysis of Very Large, Hilar Lymph Node Positive Non-Small Cell Lung Cancer Using the National Cancer Data Base

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results Molecular.

Presentation transcript:

Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND/UCLA Appropriateness Method Karyn A. Goodman, MD, MS, Caroline E. Patton, MA, George A. Fisher, MD, PhD, Sarah E. Hoffe, MD, Michael G. Haddock, MD, Parag J. Parikh, MD, John Kim, MD, Nancy N. Baxter, MD, PhD, Brian G. Czito, MD, Theodore S. Hong, MD, Joseph M. Herman, MD, MS, Christopher H. Crane, MD, Karen E. Hoffman, MD Practical Radiation Oncology Volume 6, Issue 3, Pages 166-175 (May 2016) DOI: 10.1016/j.prro.2015.11.014 Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

Figure 1 Appropriateness of neoadjuvant short-course radiation therapy. Practical Radiation Oncology 2016 6, 166-175DOI: (10.1016/j.prro.2015.11.014) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

Figure 2 Appropriateness of neoadjuvant chemotherapy alone. Practical Radiation Oncology 2016 6, 166-175DOI: (10.1016/j.prro.2015.11.014) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

Figure 3 Appropriateness of no neoadjuvant therapy. Practical Radiation Oncology 2016 6, 166-175DOI: (10.1016/j.prro.2015.11.014) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

Figure 4 Appropriateness of adjuvant chemoradiation (plus ≥4 months of chemotherapy). Practical Radiation Oncology 2016 6, 166-175DOI: (10.1016/j.prro.2015.11.014) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

Figure 5 Appropriateness of adjuvant chemotherapy alone. Practical Radiation Oncology 2016 6, 166-175DOI: (10.1016/j.prro.2015.11.014) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

Figure 6 Appropriateness of definitive endorectal brachytherapy. ECOG, Eastern Cooperative Oncology Group. Practical Radiation Oncology 2016 6, 166-175DOI: (10.1016/j.prro.2015.11.014) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions

Figure 7 Appropriateness of definitive chemoradiation plus endorectal brachytherapy. ECOG, Eastern Cooperative Oncology Group. Practical Radiation Oncology 2016 6, 166-175DOI: (10.1016/j.prro.2015.11.014) Copyright © 2015 American Society for Radiation Oncology. Terms and Conditions